Company
NRx Pharmaceuticals
WilmingtonBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
NRx Pharmaceuticals, Inc has appointed Michael Abrams as its permanent Chief Financial Officer, succeeding Interim-CFO Richard Narido. Dr Jonathan Javitt, Chairman, CEO and Chief Scientist of NRx Pharmaceuticals, expressed excitement for Mike's experience in the biotechnology sector and investment banking, emphasizing the company's aim to become a revenue-generating, profitable biotechnology company.
Quick answer
NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024). NRx Pharmaceuticals is based in Wilmington, Delaware, United States.
- What did NRx Pharmaceuticals announce on November 18, 2024?
- NRx Pharmaceuticals, Inc has appointed Michael Abrams as its permanent Chief Financial Officer, succeeding Interim-CFO Richard Narido. Dr Jonathan Javitt, Chairman, CEO and Chief Scientist of NRx Pharmaceuticals, expressed excitement for Mike's experience in the biotechnology sector and investment banking, emphasizing the company's aim to become a revenue-generating, profitable biotechnology company.
- What does NRx Pharmaceuticals do?
- NRx Pharmaceuticals, Inc. draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients.
- Where is NRx Pharmaceuticals based?
- NRx Pharmaceuticals is based in Wilmington, Delaware, United States.
- Which similar companies made leadership changes around the same time?
- Arecor Therapeutics PLC (November 18, 2024), BerGenBio ASA (November 20, 2024), Tarsus Pharmaceuticals (November 5, 2024) and TORL BioTherapeutics (December 2, 2024) also announced leadership changes within 45 days of NRx Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Byondis Appoints Louis Denis, M.D. as Chief Medical Officer (November 19, 2024)
Who to call at NRx Pharmaceuticals, and when
A new leader at NRx Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NRx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NRx Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NRx Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NRx Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NRx Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.